Trump’s administration has made it harder for families to get vaccines and medicine. It removed outside experts from the Centers for Disease Control and Prevention’s vaccine advisory group and cut public-health staff. It also changed rules on reproductive health: it weakened enforcement of the federal law that protects access to clinics, pulled back the rule that requires emergency rooms to provide necessary care in emergencies (including pregnancy emergencies), froze money for the main federal family-planning program, and blocked some payments from the public health insurance program for low-income people to Planned Parenthood. Military families lost reimbursement for travel related to abortion and fertility care. On drug prices, the White House announced a 100% tax on many imported brand-name drugs and promoted a plan called “TrumpRx” that mostly doesn’t lower what people with private insurance pay. The result is fewer providers, more paperwork, and higher costs standing between families and the care they need.
The example content is only intended to illustrate potential uses of the included research, it has not been vetted or cleared for paid distribution.
- On June 9, 2025, HHS removed all 17 members of CDC’s Advisory Committee on Immunization Practices (ACIP) and “reconstituted” the panel under Secretary Robert F. Kennedy Jr. (hhs.gov)
- Former ACIP members and professional groups warned the purge weakens U.S. immunization policy and could erode access to lifesaving vaccines. (reuters.com)
- The revamped ACIP moved to review long‑approved shots and the childhood schedule, with some appointees known for vaccine skepticism. (cnbc.com)
- In March 2025, HHS announced a reorganization with large workforce reductions—including thousands at CDC and FDA—raising concerns about public‑health capacity to sustain vaccination programs. (govexec.com)
¶ Republicans and the Trump administration restricted access to reproductive medicine
- On January 24, 2025, President Trump signed Executive Order 14182 “Enforcing the Hyde Amendment,” revoking prior orders that expanded reproductive health access and directing agencies to end funding for elective abortions. (federalregister.gov)
- In late May–June 2025, CMS rescinded the Biden-era EMTALA guidance clarifying that emergency abortions are required to stabilize patients, increasing legal uncertainty for hospitals; HHS said it would still enforce EMTALA, but providers warned of confusion and risk to patients. (foleyhoag.com)
- On January 25, 2025, the Justice Department narrowed enforcement of the FACE Act, dismissing pending cases and limiting new prosecutions for obstructing access to reproductive health clinics. (reuters.com)
- On April 24, 2025, HHS withheld $65.8 million in Title X grants—about a quarter of the network—leaving several states with no Title X providers and prompting litigation. (aclu.org)
- Reporting the same week documented that the freeze reached nine Planned Parenthood affiliates and multiple states, severely curtailing contraception, cancer screening, and STI services for low‑income patients. (washingtonpost.com)
- H.R. 1 (Public Law 119‑21), signed July 4, 2025, imposed a one‑year federal Medicaid payment ban on nonprofit “essential community providers” that provide abortions beyond Hyde exceptions and received ≥$800,000 in 2023—effectively targeting Planned Parenthood; courts have partially enjoined aspects, and states issued implementation bulletins. (kff.org)
- Clinics have already reduced or suspended services because of these federal funding restrictions, including primary care and reproductive services relied on by Medicaid patients. (apnews.com)
- In January 2025, DoD eliminated travel reimbursement for service members seeking abortions and fertility treatment, reducing access for military families. (apnews.com)
- On September 30, 2025, the administration announced 100% tariffs on imported branded drugs and a “TrumpRx” deal highlighted by voluntary price cuts largely affecting Medicaid and a narrow set of products. (ft.com)
- Health policy experts noted that Medicaid already receives deep discounts, questioning real‑world savings for most consumers as tariffs threaten higher prices in commercial markets. (washingtonpost.com)